John Sninsky

John Sninsky is currently serving as the Chief Scientific Officer and Chief Innovation Officer at SuperFluid Dx since October 2023. In this role, John is contributing to the company's efforts in precision medicine, specifically focusing on the early detection of Alzheimer's Disease through a liquid biopsy RNA-Seq machine learning platform. Prior to this position, John held the same titles at Molecular Stethoscope.